NeoVirTech opens a new laboratory at the Toulouse Cancer Research Center (CRCT)

NeoVirTech opens a new laboratory at the Toulouse Cancer Research Center (CRCT)

NeoVirTech SAS opens a new laboratory at the Toulouse Cancer Research Center (CRCT) to structure its anti-cancer programs towards the creation of a patient-oriented theranostics platform, and to promote drug development.

NeoVirTech provides access to its ANCHORTM technology platform to develop disruptive models for the investigation of cancer-associated mechanisms and the preclinical development of oncolytic virotherapies.

More specifically, NeoVirTech and CRCT Team 10 aim to develop a rapid and reliable theranostic platform to ensure the efficacy of oncolytic virotherapies in cancer patients.

Long-term collaboration will ensure patient benefits and reduce the time to decision for individualised cancer therapies.

We are pleased to announce our partnership with VirHealth!

We are pleased to announce our partnership with VirHealth!

VirHealth SAS and NeoVirTech SAS announce the creation of a strategical alliance to create one of the most advanced private virus disinfection platform in Europe.


VirHealth and NeoVirTech join their virology expertise to provide customers one of the most extended virus disinfection measurement and R&D platform in France and in Europe. This alliance will allow the partners to combine their respective expertise in an integrated offer dedicated to increase knowledge in virus persistence in the environment, virus disinfection procedure and to provide customer state of the art models for the measurement of disinfection procedures using innovative and standardized approaches.

Picture of the month, March 2022

Influenza infection

Picture of the month, March 2022

Purification of a recombinant influenza H1N1 virus expressing a fluorescent protein. Nuclei in blue, infected cells in yellow. We thought the color code is appropriated. Work by Thomas Figueroa and Quentin Husson.

Influenza infection